Clin Rheumatol. 2025 Sep 24. doi: 10.1007/s10067-025-07602-w. Online ahead of print. ABSTRACT BACKGROUND: While the relationship between serum uric acid […]
J Ophthalmic Inflamm Infect. 2025 Sep 24;15(1):67. doi: 10.1186/s12348-025-00530-5. ABSTRACT BACKGROUND: The purpose of this case report is to describe
Pediatr Res. 2025 Sep 24. doi: 10.1038/s41390-025-04424-z. Online ahead of print. ABSTRACT BACKGROUND: Limited studies focused on characteristics of childhood-onset
Nat Med. 2025 Sep 24. doi: 10.1038/s41591-025-03937-8. Online ahead of print. ABSTRACT Systemic lupus erythematosus (SLE) remains refractory to conventional
Nat Commun. 2025 Sep 24;16(1):8361. doi: 10.1038/s41467-025-62058-5. ABSTRACT Applying artificial intelligence (AI) for systematic literature review holds great potential for
Nat Immunol. 2025 Sep 24. doi: 10.1038/s41590-025-02267-8. Online ahead of print. ABSTRACT Fibroblasts sculpt the architecture and cellular microenvironments of
Nat Commun. 2025 Sep 24;16(1):8368. doi: 10.1038/s41467-025-62419-0. ABSTRACT The extensive co-occurrence of cardiovascular diseases (CVDs), as evidenced by epidemiological studies,
There has been a rapid increase in the global number of cancer cases and deaths between 1990 and 2023, despite
Rheumatology Advances in Practice, 2022. Lower urinary tract symptoms in systemic sclerosis: a detailed investigation. Greta Pacini, Rheumatology, …
Rheumatoid arthritis begins long before symptoms jjcush@gmail.com Wed, 09/24/2025 – 19:27
Monthly survey – 351 ArthritisPower #RA Registry pts reported 523 nonserious infxns (31% ; most URI), few resulted in https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg
Int Immunopharmacol. 2025 Sep 23;166:115573. doi: 10.1016/j.intimp.2025.115573. Online ahead of print. ABSTRACT Rheumatoid arthritis (RA) is one of the most
J Clin Oncol. 2025 Sep 24:JCO2500925. doi: 10.1200/JCO-25-00925. Online ahead of print. ABSTRACT In the POLARIX study (ClinicalTrials.gov identifier: NCT03274492),
Sci Adv. 2025 Sep 26;11(39):eadu9772. doi: 10.1126/sciadv.adu9772. Epub 2025 Sep 24. ABSTRACT Dry eye disease (DED) is characterized by chronic
DERM on RheumNow Podcast (September 2025) Content curated for dermatologists and skin deep HCPs – on Psoriasis, CLE, https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
SANTA BARBARA, CA — September 23, 2025—Cottage Health has opened Cottage Rheumatology Clinic, a new specialty care clinic within Cottage
… Rheumatology (ACR) response criteria assessed at 12, 24, 36, and 52 weeks. TAKEAWAY: At week 24, no significant difference
“This study builds on years of work identifying and tracking people at risk for RA,” said Kevin Deane, MD, professor
Treatment responses were assessed based on the percent of improvements in the American College of Rheumatology (ACR), Assessment of …
QD Clinic: Stick or twist (when not to change treatment Dr. Richard Conway, Dublin, discusses a case about when not
Rheum to Breathe Journal Club tammytilley@gm… Wed, 09/24/2025 – 13:32 Education/ACR/EULAR Drug Safety Novel Rx Other Rheumatoid Arthritis Scleroderma/Raynauds This
Assessing ILD in Rheumatology Janet Pope, MD, shares practical insights on how rheumatologists should assess ILD in the https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john…
Scleroderma-associated Interstitial Lung Disease Since the first placebo-controlled randomized trial published nearly https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Wed, 09/24/2025 – 11:30 RheumNow Dr.
Dr. Courtney Stull Cottage Health has opened Cottage Rheumatology Clinic, a new specialty care clinic within Cottage Medical Group.
Moral courage is the strength to speak up even when doing so may have negative consequences. This is vital skill
In this episode, Dr. Kumar talks about the fascinating and intriguing secret lives of rheumatologists—real life superheroes. The post <em>Rheum
Greater comorbidity burden (per Rheumatic Disease Comorbidity Index point: aHR, 1.26; 95% CI, 1.25-1.27);; Use of urate-lowering therapy (aHR, 1.30; …
